1-4 of 4
Chris Davis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Measurable Residual Disease as Predictor of Post-Day +100 Relapses Following Allografting in Adult AML

Naveed Ali, Megan Othus, Eduardo Rodríguez-Arbolí, Corentin Orvain, Filippo Milano, Brenda M Sandmaier, Chris Davis, Ryan Basom, Fred R Appelbaum, Roland B. Walter
Journal: Blood Advances
Blood Adv bloodadvances.2024013214.
https://doi.org/10.1182/bloodadvances.2024013214
Published: 2024
Journal Articles

EASIX-1year and late mortality after allogeneic stem cell transplantation

Clinical Trials & Observations
Lambros Kordelas, Tobias Terzer, Ted Gooley, Chris Davis, Brenda M. Sandmaier, Mohamed Sorror, Olaf Penack, Nigel D. E. Schaeper, Igor W. Blau, Dietrich Beelen, Aleksandar Radujkovic, Peter Dreger, Thomas Luft
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5374–5381.
https://doi.org/10.1182/bloodadvances.2022008617
Published: 2023
Includes: Supplemental data
Journal Articles

HIGH-2-LOW risk model to predict venous thromboembolism in allogeneic transplant patients after platelet engraftment

Clinical Trials & Observations
Kylee L. Martens, Wilson L. da Costa, Jr, Christopher I. Amos, Chris Davis, Madeline Kesten, Stephanie J. Lee, Neil A. Zakai, David A. Garcia, Ang Li
Journal: Blood Advances
Blood Adv (2021) 5 (1): 167–175.
https://doi.org/10.1182/bloodadvances.2020003353
Published: 2021
Includes: Supplemental data
Journal Articles

Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation

Clinical Trials & Observations
Ang Li, Chris Davis, Qian Wu, Shan Li, Madeline F. Kesten, Leona A. Holmberg, Ajay K. Gopal, David A. Garcia
Journal: Blood Advances
Blood Adv (2017) 1 (12): 707–714.
https://doi.org/10.1182/bloodadvances.2017006130
Published: 2017